Skip to main content
Peptide Daily.
Research desk

A peptide news feed that treats sources with respect

We keep the stream editorial and source-first: regulatory updates, clinical developments, and research headlines, without mixing them into sales-y ticker copy.

FDAGLP-1

FDA Approves First Oral GLP-1 Receptor Agonist for Type 2 Diabetes

The US Food and Drug Administration approved the first oral once-daily GLP-1 receptor agonist for glycaemic control in adults with type 2 diabetes, representing a significant shift in the delivery method for this class of metabolic peptide therapeutics.

Mar 16, 2026Mar 16, 2026
GLP-1metabolicregulatory